Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122911442 | 12291144 | 2 | F | 20160322 | 20160727 | 20160421 | 20160805 | EXP | JP-BAYER-2016-070965 | BAYER | 57.00 | YR | A | M | Y | 70.00000 | KG | 20160805 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122911442 | 12291144 | 1 | PS | NEXAVAR | SORAFENIB | 1 | Oral | DAILY DOSE 800 MG | Y | Y | 21923 | 800 | MG | FILM-COATED TABLET | |||||
| 122911442 | 12291144 | 2 | SS | NEXAVAR | SORAFENIB | 1 | Oral | DAILY DOSE 400 MG | Y | Y | 21923 | 400 | MG | FILM-COATED TABLET | |||||
| 122911442 | 12291144 | 3 | SS | NEXAVAR | SORAFENIB | 1 | Oral | DAILY DOSE 400 MG | Y | Y | 21923 | 400 | MG | FILM-COATED TABLET | |||||
| 122911442 | 12291144 | 4 | C | BLOPRESS | CANDESARTAN CILEXETIL | 1 | Oral | DAILY DOSE 8 MG | 0 | 8 | MG | TABLET | |||||||
| 122911442 | 12291144 | 5 | C | REBAMIPIDE | REBAMIPIDE | 1 | Oral | DAILY DOSE 200 MG | 0 | 200 | MG | TABLET | |||||||
| 122911442 | 12291144 | 6 | C | FLUITRAN | TRICHLORMETHIAZIDE | 1 | Oral | DAILY DOSE 1 MG | 0 | 1 | MG | TABLET | |||||||
| 122911442 | 12291144 | 7 | C | SENNOSIDE | SENNOSIDES | 1 | Oral | DAILY DOSE 12 MG | 0 | 12 | MG | TABLET | |||||||
| 122911442 | 12291144 | 8 | C | FAMOTIDIN | 2 | Oral | DAILY DOSE 20 MG | 0 | 20 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122911442 | 12291144 | 1 | Hepatocellular carcinoma |
| 122911442 | 12291144 | 2 | Hepatocellular carcinoma |
| 122911442 | 12291144 | 3 | Hepatocellular carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122911442 | 12291144 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122911442 | 12291144 | Blood creatine phosphokinase increased | Blood creatine phosphokinase increased |
| 122911442 | 12291144 | Palmar-plantar erythrodysaesthesia syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122911442 | 12291144 | 1 | 20160315 | 20160321 | 0 | |
| 122911442 | 12291144 | 2 | 20160322 | 20160328 | 0 | |
| 122911442 | 12291144 | 3 | 20160408 | 20160412 | 0 |